Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
about
Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3' untranslated regionBiphasic modulation of atherosclerosis induced by graded dietary copper supplementation in the cholesterol-fed rabbitCeruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism.Molecular mechanisms of the copper dependent oxidation of low-density lipoprotein.Infection and inflammation-induced proatherogenic changes of lipoproteins.Experimental evidence for the cardioprotective effects of red wine.Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.Anti-beta 2-glycoprotein I autoantibodies and atherosclerosis.Pain-associated biomarkers in breast cancerGenetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.Immunomodulation and vaccination for atherosclerosis.Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems.Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell coculturesOxidized low-density lipoprotein.Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces.Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?The therapeutic efficacy of intensive medical therapy in ameliorating high-density lipoprotein dysfunction in subjects with type two diabetes.Autoimmune-mediated atherothrombosis.Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.Ceruloplasmin gene expression in the murine central nervous system.Lipid peroxidation and antioxidant enzymes activity in Plasmodium vivax malaria patients evolving with cholestatic jaundice.HDL inflammation and atherosclerosis: current and future perspectives.Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.Low-density lipoprotein modification by normal, myeloperoxidase-deficient and NADPH oxidase-deficient granulocytes and the impact of redox active transition metal ions.Positive correlation of serum HDL cholesterol with blood mercury concentration in metabolic syndrome Korean men (analysis of KNANES 2008-2010, 2013).Role of ceruloplasmin in macrophage iron efflux during hypoxia.Copper-dependent inflammation and nuclear factor-kappaB activation by particulate air pollution.The inhibition of foam cell formation by sodium diethyldithiocarbamate.Reduction of Cu(II) by lipid hydroperoxides: implications for the copper-dependent oxidation of low-density lipoprotein.Influence of chloroquine treatment and Plasmodium falciparum malaria infection on some enzymatic and non-enzymatic antioxidant defense indices in humans.Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aortaParaoxonase as a risk marker for cardiovascular disease: facts and hypotheses.Ceruloplasmin is an endogenous inhibitor of myeloperoxidase.Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia.Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study.Inhibition of oxidized low-density lipoprotein-induced apoptosis in endothelial cells by nitric oxide. Peroxyl radical scavenging as an antiapoptotic mechanism.Ceruloplasmin as low-density lipoprotein oxidase: activation by ascorbate and dehydroascorbate.Homocysteine promotes the LDL oxidase activity of ceruloplasmin.Ceruloplasmin and atrial fibrillation: evidence of causality from a population-based Mendelian randomization study.Insulin resistance and inflammation markers: correlations in obese adolescents.
P2860
Q24554320-9B15FE97-568E-4ADA-83AA-50104DE083C0Q28363689-B9A2FD47-399C-48ED-8008-DBBC63AC1B2FQ30423997-28BFD3E6-A3D3-4931-BB24-4CC80E09436DQ33588423-86891E30-2049-4731-A1F9-BB601DCF2378Q33935040-CDEF7CB4-B740-4157-9F7B-C84753C3579BQ34594669-83DA25C5-2CFE-4BF8-AE86-DE89C091184DQ34767602-EB19967A-25BF-417D-B920-27FADD1DD004Q34790028-24CCB568-4975-4E55-8146-9748F6D8290DQ35422696-D71C398C-D44E-4EF9-998F-14C5B8EAAC22Q35607880-8E6B0140-A022-4190-BD06-FD194AE7C472Q35753555-09747FDC-89A6-408F-871F-C3F1F2099A60Q35764845-ADBCCF5F-ACB0-483C-A94B-E3D294E65084Q35768215-BAFE917D-AB61-4CF7-8F57-B4819A4116BCQ35860737-BDB82A67-A5B1-4F0A-9832-4799756A32E3Q36601900-9D40C1C4-34A8-4900-9669-56D44ABA1FDCQ37113383-96D66312-5B4E-4E02-8D48-BDEFC9E7D48DQ37211868-45E8FC11-B2DA-40B4-84D5-B555C57CBD6EQ37283009-5ABA3D2B-6E4B-46B9-9122-2CABED546D83Q37351883-E89F1650-37D0-4435-B410-32930B34B543Q37357207-23001418-4E16-45EF-934C-792372D84144Q37357711-60B1E073-7385-4FE2-B80E-AA02EC00F484Q37608502-39922FCC-1191-4324-A9F2-180CE4F8B574Q37621571-C0137F21-176A-4CF1-BA12-60488C3BC988Q38363606-BB98B0A4-AD1B-4220-AD69-93B36645E662Q39827556-7E328595-98C0-4006-887A-5600E2C86F25Q40638208-C2693162-71DF-440C-9FEC-96D1752EFD24Q41010499-C7C68A7B-2C2A-4A8F-A748-D9EA8A3AB702Q41304624-8C7B6B5D-1CFD-4106-8B01-379404A7F26FQ41859943-58972DD0-3A7E-4A89-B020-D53F98451010Q41916178-7245C464-119E-4F54-B49E-2E8F1158C642Q41951247-63AA6240-2ED2-4E63-9263-5DE5B57BC791Q42539552-535B6245-55FB-4F5D-9C8F-9D4A3849AD22Q42739533-F4C2DA05-A871-46A9-9CF4-B5BEF5D2F379Q43300344-A3C123B0-ABA0-48D1-AFF9-9F1AD6BB8698Q43543562-D0DD2A61-5FFF-4CB4-AD6B-B51CA733DF73Q43560131-85F14B9A-4369-4A20-BEC7-DA09F8C48390Q43678257-083CDC9A-115E-4596-9E5E-222E681C67F2Q44219160-43B2CD91-9301-40FB-B825-DC265B373F8EQ44516862-2AD0CE03-12B5-41DA-B719-BD7D87C3DEFBQ45310003-1505F6F8-6B07-40D2-A2DC-FB5745C09783
P2860
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@ast
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@en
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@nl
type
label
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@ast
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@en
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@nl
prefLabel
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@ast
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@en
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@nl
P2093
P2860
P356
P1476
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
@en
P2093
P2860
P304
P356
10.1172/JCI117127
P407
P577
1994-04-01T00:00:00Z